Integrated Diagnostics (IDHC) Competitors

Integrated Diagnostics (LON:IDHC) and Diaceutics (LON:DXRX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, community ranking, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Is IDHC or DXRX more profitable?

Integrated Diagnostics has a net margin of 17.21% compared to Diaceutics' net margin of -10.90%. Integrated Diagnostics' return on equity of 30.45% beat Diaceutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integrated Diagnostics	17.21%	30.45%	9.69%
Diaceutics	-10.90%	-7.15%	-6.06%

Do analysts rate IDHC or DXRX?

Diaceutics has a consensus price target of GBX 160, indicating a potential upside of 29.03%. Given Diaceutics' stronger consensus rating and higher possible upside, analysts plainly believe Diaceutics is more favorable than Integrated Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integrated Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do institutionals & insiders have more ownership in IDHC or DXRX?

43.0% of Integrated Diagnostics shares are held by institutional investors. Comparatively, 52.4% of Diaceutics shares are held by institutional investors. 34.0% of Integrated Diagnostics shares are held by company insiders. Comparatively, 34.3% of Diaceutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has preferable valuation and earnings, IDHC or DXRX?

Integrated Diagnostics has higher revenue and earnings than Diaceutics. Diaceutics is trading at a lower price-to-earnings ratio than Integrated Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integrated Diagnostics	£23.29T	0.00	£4.01T	£0.03	13.38
Diaceutics	£26.08M	4.01	-£2.84M	-£3.37	-36.78

Does the MarketBeat Community believe in IDHC or DXRX?

Integrated Diagnostics received 41 more outperform votes than Diaceutics when rated by MarketBeat users. However, 88.24% of users gave Diaceutics an outperform vote while only 65.12% of users gave Integrated Diagnostics an outperform vote.

Company	Underperform	Outperform
Integrated Diagnostics	Outperform Votes 56 65.12%	Underperform Votes 30 34.88%
Diaceutics	Outperform Votes 15 88.24%	Underperform Votes 2 11.76%

Which has more volatility and risk, IDHC or DXRX?

Integrated Diagnostics has a beta of 0.59, suggesting that its share price is 41% less volatile than the S&P 500. Comparatively, Diaceutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Does the media favor IDHC or DXRX?

In the previous week, Diaceutics had 6 more articles in the media than Integrated Diagnostics. MarketBeat recorded 6 mentions for Diaceutics and 0 mentions for Integrated Diagnostics. Diaceutics' average media sentiment score of 1.09 beat Integrated Diagnostics' score of 0.00 indicating that Diaceutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Integrated Diagnostics	Neutral
Diaceutics	Positive

Summary

Integrated Diagnostics and Diaceutics tied by winning 9 of the 18 factors compared between the two stocks.